Ethical considerations in clinical training, care and research in psychopharmacology

被引:2
作者
Strous, Rael D. [1 ,2 ]
机构
[1] Beer Yaakov Mental Hlth Ctr, Chron Inpatient Unit, IL-70350 Beer Yaagov, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
关键词
Ethics; informed consent; mindfulness; psychopharmacology; responsibility; PSYCHOSIS RISK SYNDROME; DEEP BRAIN-STIMULATION; CONFLICTS-OF-INTEREST; MENTAL-ILLNESS; SCHIZOPHRENIA RESEARCH; PSYCHIATRIC RESEARCH; MEDICAL-ETHICS; DSM-V; ISSUES; CONSENT;
D O I
10.1017/S1461145710001112
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Psychopharmacology is a powerful tool in psychiatry; however, it is one that demands responsibility in order to deal with the ethical complexities that accompany advances in the field. It is important that questions are asked and that ethical mindfulness and sensitivity are developed along with clinical skills. In order to cultivate and deepen ethical awareness and subsequently solve issues in optimal fashion, investment should be made in the development of an ethical decision-making process as well as in education in the ethics of psychopharmacology to trainees in the field at all stages of their educational development. A clear approach to identifying ethical problems, engaging various ethical concepts in considering solutions and then applying these principles in problem resolution is demanded. An openness in identifying and exploring issues has become crucial to the future development and maturation of psychopharmacologists, both research and clinical. Consideration must be given to the social implications of psychopharmacological practice, with the best interests of patients always paramount. From both a research and clinical perspective, psychopharmacology has to be practised with fairness, sensitivity and ethical relevance to all. While ethical issues related to psychopharmacological practice are varied and plentiful, this review focuses on advances in technology and biological sciences, personal integrity, special populations, and education and training.
引用
收藏
页码:413 / 424
页数:12
相关论文
共 67 条
[1]   Deep brain stimulation for psychiatric disorders [J].
不详 .
NEUROSURGERY, 2002, 51 (02) :519-519
[2]  
[Anonymous], MADHOUSE TRAGIC TALE
[3]   Assessment of patients' competence to consent to treatment [J].
Appelbaum, Paul S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (18) :1834-1840
[4]   Placebo-controlled studies in depression:: necessary, ethical and feasible [J].
Baldwin, D ;
Broich, K ;
Fritze, J ;
Kasper, S ;
Westenberg, H ;
Möller, HJ .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2003, 253 (01) :22-28
[5]  
Benjamin J, 2002, ISRAEL J PSYCHIAT, V39, P86
[6]  
Billick SB, 1998, J AM ACAD PSYCHIATRY, V26, P587
[7]   Pharmacogenetics: ethical problems and solutions [J].
Breckenridge, A ;
Lindpaintner, K ;
Lipton, P ;
McLeod, H ;
Rothstein, M ;
Wallace, H .
NATURE REVIEWS GENETICS, 2004, 5 (09) :676-680
[8]   Working with the institutional review board [J].
Byerly, Wesley G. .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (02) :176-184
[9]   Curricular approaches to research ethics training for psychiatric investigators [J].
Chen, DT .
PSYCHOPHARMACOLOGY, 2003, 171 (01) :112-119
[10]   The psychosis risk syndrome and its proposed inclusion in the DSM-V: A risk-benefit analysis [J].
Corcoran, Cheryl M. ;
First, Michael B. ;
Cornblatt, Barbara .
SCHIZOPHRENIA RESEARCH, 2010, 120 (1-3) :16-22